Patents by Inventor Charlotte Christine Thim Hansen

Charlotte Christine Thim Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GLP-1 RECEPTOR AGONISTS IN DEMENTIA
    Publication number: 20230302094
    Abstract: The present invention relates to improved medical therapies for all forms and stages of dementia involving administration of (i) GLP-1 receptor agonists to subjects with metabolic syndrome or (ii) semaglutide.
    Type: Application
    Filed: June 12, 2023
    Publication date: September 28, 2023
    Applicant: Novo Nordisk A/S
    Inventors: Sarah Friedrich, Charlotte Christine Thim Hansen, Lotte Bjerre Knudsen, Anna Secher
  • GLP-1 RECEPTOR AGONISTS IN DEMENTIA
    Publication number: 20220280612
    Abstract: The present invention relates to improved medical therapies for all forms and stages of dementia involving administration of (i) GLP-1 receptor agonists to subjects with metabolic syndrome or (ii) semaglutide.
    Type: Application
    Filed: May 4, 2022
    Publication date: September 8, 2022
    Inventors: Sarah Friedrich, Charlotte Christine Thim Hansen, Lotte Bjerre Knudsen, Anna Secher